Cerapedics Leadership Team

Glen Kashuba, CEO

Glen Kashuba has over 30 years of executive management experience leading medical device companies. Prior to becoming CEO in 2013, Glen served as the Worldwide President of Spine & Bone Healing Technologies, Inc., a Biomet company, and concurrently served as Senior Vice President on Biomet’s Worldwide Operating Board, encompassing Biomet’s orthopedics, spine, trauma, biologics and sports medicine businesses. He also served as Worldwide President for Biomet Spine and Trauma. During his tenure at Biomet, he launched more than 25 new products. Prior to Biomet, Glen held a number of division president roles at Johnson & Johnson, including Worldwide President of Cordis Endovascular, Cordis Neurovascular and Codman Neuro Sciences, and U.S. President of DePuy Spine.
  – Connect with Glen on LinkedIn.

Jeffrey G. Marx, Ph.D., President & COO

Jeffrey Marx serves as President & Chief Operating Officer, overseeing regulatory, quality, manufacturing, and R&D efforts for the company. With some two decades of experience in executive management with medical device companies, he brings considerable expertise in research & development, commercialization, sales management, business development and strategic planning. His experience includes over 13 years with Orthovita, where he was VP Corporate Development. When Orthovita was acquired by Stryker Orthobiologics, Jeff led the team that integrated the two companies; he continued as VP Corporate Development at Stryker. He has earned a Ph.D. in Ceramic Engineering from Missouri University of Science and Technology, Rolla MO.
  – Connect with Jeffrey on LinkedIn.

Drew Trivisonno, CFO

Drew Trivisonno brings two decades of financial operations management, and 10 years of experience in medical device mergers & acquisitions, along with debt & equity financing into his role as Cerapedics’ CFO. Previously, as VP with the venture capital firm Viscogliosi Bros., LLC, Drew helped to manage financing and acquisition projects with such companies as Knee Creations, Zimmer Corporation, Stryker, New Health Capital, PDL Biopharma, Small Bone Innovations, and many more. He earned his B.Sc. in Accounting at Babson College, Babson Park MA.
  – Connect with Drew on LinkedIn.

Andrew W. Barnes, VP of U.S. Sales

Andrew Barnes is an experienced leader within medical device sales, having held various leadership positions with leading companies in biologics, spine, orthopedic and maxillofacial medicine. Beginning his career with Synthes Trauma, Spine & Maxillofacial, Andy worked with such leading companies as Globus Medical, Stryker Orthobiologics/Orthovita, Medtronic and MacroPore Biosurgery before joining Cerapedics as Vice President of U.S. Sales.
 – Connect with Andrew on LinkedIn.

Jerome Connor, Ph.D., VP of Research and Development

Jerome Connor brings more than three decades of experience – both academic and corporate – in research and product development and specializes in the areas of soft tissue, hard tissue, and cell-based biology to his position as VP of Research and Development at Cerapedics. His previous positions include Assistant Professor at the University of Texas M.D. Anderson Cancer Center, and more than 20 years as Senior Director of Research and Development at LifeCell Corporation. Jerome earned his Ph.D. in Biochemistry at the University of Tennessee and received post-doctoral training at the M.D. Anderson Cancer Center of the University of Texas.
– Connect with Jerome on LinkedIn.

Roger N. White, VP of Clinical and Regulatory Affairs

Roger White has amassed extensive regulatory, clinical and product development experience in his 35 years in the medical device industry. Before joining Cerapedics as VP of Clinical and Regulatory Affairs, his prior positions include founder and president of Phiama, Inc.; COO of Spine Wave, Inc., VP & Group Director of Quality Systems and Regulatory Affairs for Medtronic Surgical Navigation among others. Roger received B.S. and M.S. degrees in Biomedical Engineering from Louisiana Tech University. He has obtained more than 60 510(k) clearances, for devices in orthopedics and spine, image-guided surgery, microwave ablation and many more.
  – Connect with Roger on LinkedIn.

Andy Woods, Director of Commercial Development

Andy Woods has worked eight years in commercial development with Cerapedics. He acquired his expertise in the orthopaedic industry in senior level sales and marketing roles in reconstruction, trauma, spine and biologics. Prior to joining Cerapedics, he held leadership roles in Howmedica, Biomet, Orthovita and Orthogem. Over his 25-year career in the field, he has established commercial and marketing structures in both established firms and startups. Based in the UK, Andy works in the international arena, with subsidiary companies and distributor networks in all regions of the globe.
– Connect with Andy on LinkedIn.

Scott Johnson, Ph.D., Director of Clinical Education and Marketing

Bringing more than 15 years of experience to his role, Scott Johnson is responsible for strategic planning and tactical implementation of programs in professional education and clinical marketing. Scott’s perspective spans the technical and commercial aspects of orthopaedics, with roles in research and development, product innovation and clinical and business development. He holds B.Sc. and Ph.D. degrees with concentrations in musculoskeletal biology and biomechanics. Scott is based in the UK.
– Connect with Scott on LinkedIn.

Katie Davis, Director of Research and Development 

Katie Davis has more than 15 years of experience in medical device Research & Development. Prior to beginning her tenure with Cerapedics, Katie worked as a product development engineer and as R&D manager with Dentsply. She has B.S. and M.S. degrees in chemical engineering. She applies her decade of work with P-15 technology to further advance the development of the i-FACTOR ™ bone graft portfolio.
– Connect with Katie on LinkedIn.

Mark Bowerman, Director of Quality Systems and Regulatory Affairs

Mark Bowerman has experience in R&D, quality, and regulatory affairs with both ground level start-ups and large corporations, earned over his 30-year career in the medical device industry. In previous positions with such companies as such as Baxter and Dentsply, Mark has developed and implemented quality management systems that are adaptable to company needs and regulation-compliant. He has executed regulatory strategies and obtained market clearance and approvals for numerous products in both the U.S. and international markets.
– Connect with Mark on LinkedIn.